4 months ago

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

The Guardian
4 months ago

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

FT
GSK Nuvalent USA

←Top Latest Headlines